Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Regeneron Pharmaceuticals
Today
Create an eToro account to buy REGN stock on a secure, user-friendly, multi-asset trading platform.
Buy Regeneron Pharmaceuticals
REGN Price
Regeneron Pharmaceuticals REGN
Buy REGN

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Regeneron Pharmaceuticals News

REGN Price

Regeneron Pharmaceuticals REGN

$712.13-1.58(-0.22%)(1D)

REGN Stock Price Chart

-5.06%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Regeneron Pharmaceuticals share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Regeneron Pharmaceuticals share price today is 712.13, reflecting a -0.22% change over the last 24 hours and -3.52% over the past week. The current market capitalization of REGN is 78.51B with an average volume in the last three months of 825322.56. The stock has a P/E ratio of 17.68 and a dividend yield of 0%. With the stock’s beta sitting at 0.59
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$78.51B
Day’s Range
i
Shows the high and low prices of the day.
692.06 - 798.8
52W Range
i
Shows the high and low prices of the last year.
683.29 - 1208.59
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
825322.56
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
17.68
Revenue
i
The total income generated by this company’s goods and services last year.
$13.85B
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$714.47
EPS
i
A company’s total earnings divided by the number of shares it has issued.
40.41
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.59
What Is Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals Inc. is an American biotechnology company headquartered in Westchester County, New York. The firm is involved in the discovery, development and commercialisation of various medical solutions for patients suffering with eye diseases, allergic and inflammatory diseases, various cancers, cardiovascular and metabolic diseases, chronic pain, hematologic diseases, infectious diseases and rare diseases. The firm was founded in 1988.

Current commercialised products available from the firm include Dupixent, for the treatment of moderate-to-severe atopic dermatitis (eczema), Evkeeza, a treatment for the high cholesterol condition homozygous familial hypercholesterolemia (HoFH), and Eylea, for the treatment of patients with wet Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR).

The company employs around 10,000 people worldwide, around 1,100 of whom hold an MD, PhD or PharmD degree, and who were published in more than 175 peer-reviewed publications in 2020 alone. The company has around 30 product candidates in development across numerous therapeutic areas. The firm is listed on the NASDAQ where it trades under the stock ticker REGN.

If you are interested in Regeneron Pharmaceuticals stock, you can track the share price by adding REGN stock to your digital watchlist.
Buy REGN

How can I buy Regeneron Pharmaceuticals stocks?

To purchase Regeneron Pharmaceuticals:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Regeneron Pharmaceuticals (REGN) page and place an order to buy Regeneron Pharmaceuticals.
Buy REGN
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Go to the Academy >
Graph
Buy Regeneron Pharmaceuticals
Invest in Regeneron Pharmaceuticals
Today
Create an eToro account to buy REGN stock on a secure, user-friendly, multi-asset trading platform.
Buy REGN

FAQ

The current price of REGN is 712.13.
The average price target for Regeneron Pharmaceuticals is 712.13. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Regeneron Pharmaceuticals based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Regeneron Pharmaceuticals is 78.51B
Daily Movers
Explore the biggest stocks movers on the market.
Buy REGN
Scroll to top